Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 6.7% over the past month. The stock hit a new 52-week high of $251.56 in the previous session.

Leading medical distributors McKesson (NYSE:MCK) and Cencora (NYSE:COR) will have to pay $266M in damages to Baltimore after a jury found that the companies were liable for causing the opioid ...

Revenue: US$294.0b (up 12% from FY 2023). Net income: US$1.51b (down 14% from FY 2023). Profit margin: 0.5% (down from 0.7% in FY 2023). EPS: US$7.60 (down from US$8.62 in FY 2023). Revenue was in ...

Shares of Cencora Inc. COR inched 0.47% higher to $249.97 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.02% to ...

Shares of Cencora Inc. COR slipped 0.12% to $248.79 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.29% to 5,983.99 and ...

Cencora has demonstrated robust financial performance in recent quarters, particularly in its core U.S. Healthcare segment. The company reported a mild operational beat in its latest earnings ...

Looking at the universe of stocks we cover at Dividend Channel, on 11/15/24, Cencora Inc (Symbol: COR), Royalty Pharma plc (Symbol: RPRX), and Brookline Bancorp Inc (Symbol: BRKL) will all trade ...

A jury found Texas-based healthcare products company McKesson liable for $192 million in damages and Pennsylvania-based drug wholesaler Cencora for $74 million. Baltimore accused the companies of ...

Cencora has demonstrated robust financial performance in recent quarters, particularly in its core U.S. Healthcare segment. The company reported a mild operational beat in its latest earnings release, ...